PlainRecalls
FDA Drug Moderate Class II Ongoing

Elitek (rasburicase) for injection, 7.5 mg vial, Rx Only Mfd. by Sanofi - Aventis U. S. LLC Bridgewater, NJ, 08807, NDC 0024-5151-75

Reported: August 26, 2020 Initiated: August 10, 2020 #D-1507-2020

Product Description

Elitek (rasburicase) for injection, 7.5 mg vial, Rx Only Mfd. by Sanofi - Aventis U. S. LLC Bridgewater, NJ, 08807, NDC 0024-5151-75

Reason for Recall

Failed Stability Specifications: Out of Specification result for enzyme activity levels noted during routine stability testing.

Details

Recalling Firm
Sanofi-Aventis U.S. LLC
Units Affected
7451 vials
Distribution
Nationwide in the US
Location
Bridgewater, NJ

Frequently Asked Questions

What product was recalled?
Elitek (rasburicase) for injection, 7.5 mg vial, Rx Only Mfd. by Sanofi - Aventis U. S. LLC Bridgewater, NJ, 08807, NDC 0024-5151-75. Recalled by Sanofi-Aventis U.S. LLC. Units affected: 7451 vials.
Why was this product recalled?
Failed Stability Specifications: Out of Specification result for enzyme activity levels noted during routine stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 26, 2020. Severity: Moderate. Recall number: D-1507-2020.